Voyager Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VACH research report →
Price Chart
About the company
Voyager Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
- CEO
- Adeel Rouf
- IPO
- 2024
- Employees
- 3
- HQ
- Brooklyn, NY, US
Get TickerSpark's AI analysis on VACH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,785,259
- Net Income
- $8.99M+117.1%
- EPS
- $0.36+140.0%
- OCF Growth
- +30.9%
- FCF Growth
- +30.9%
- 52W High
- $27.36
- 52W Low
- $1.72
- 50D MA
- $12.31
- 200D MA
- $11.07
- Beta
- -0.37
- RSI (14)
- 38
- Avg Volume
- 15.52K
No earnings-call transcripts are available for VACH yet.
- Free Float
- 80.0%
- Shares Outstanding
- 31.63M
- Float Shares
- 25.30M
of shares held by institutions
43 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Cowen And Company, LLC | 1.31M | ▲ 1.31M |
| Schechter Investment Advisors, LLC | 689.18K | ▼ 18.16K |
| Clear Street LLC | 45.90K | ▲ 45.73K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 12, 24 | Voyager Acquisition Sponsor Holdco LLC | buy | 5,037,500 |
| Aug 12, 24 | Rouf Adeel | buy | 5,037,500 |
| Aug 8, 24 | Voyager Acquisition Sponsor Holdco LLC | other | 0 |
| Aug 8, 24 | Intrater Jonathan | other | 0 |
| Aug 8, 24 | Rogers Alex Russell | other | 0 |
| Aug 8, 24 | Rouf Adeel | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VACH coverage
Recent articles, reports, and earnings notes.
No research on VACH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VACH report →VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
globenewswire.com · Jun 10
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
globenewswire.com · May 28
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
globenewswire.com · May 28
Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG
globenewswire.com · Mar 13
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
globenewswire.com · Mar 11
Crossingbridge Advisors LLC Acquires Shares of 46,779 Voyager Acquisition Corp. $VACH
defenseworld.net · Mar 9
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.
globenewswire.com · Mar 2
Contrasting Blaize (NASDAQ:BZAI) & Voyager Acquisition (NASDAQ:VACH)
defenseworld.net · Dec 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.